10x Genomics TXG 深 沪
等待开盘 10-07 09:30:00 美东时间
80.66
-17.080
-17.47%
华盛通- 最 高102.81
- 今 开100.00
- 成交量 901.71万股
- 最 低 58.70
- 昨 收 97.74
- 总市值 911.46万
- 52周最高 102.81
- 市盈率 静 --
- 换手率 7979.74%
- 52周最低 11.87
- 委 比 -71.96%
- 总股本 0.00亿
- 历史最高 208.99
- 量 比 2.94
- 振 幅 45.13%
- 历史最低 1.10
- 每 手 1
- 风险率 20.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多10x Genomics Begins Commercial Shipments Of Its Transcriptome Analysis Tool Atera
Atera is moving into the hands of researchers around the world, from those scaling existing spatial programs to researchers exploring spatial biology for the first time, across discovery, translational and biopharma
09-29 21:11
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets
Cathie Wood’s ARKG bought Ionis, Beam, Veracyte and Scribe Therapeutics. Here are the biotech ETFs that also hold her latest bets.
09-22 22:40
New AI ETF Bets on Healthcare's $9 Trillion Opportunity
Tema's new Healthcare AI ETF (HLTH), targets AI-powered drug discovery, diagnostics, robotics and patient care.
07-25 03:08
10x Genomics Acquires Proteintech Genomics; Financial Terms Undisclosed
10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced the acquisition of Proteintech Genomics, a division within Proteintech
06-09 21:07
William Blair Upgrades 10x Genomics to Outperform
William Blair analyst Matt Larew upgrades 10x Genomics (NASDAQ:TXG) from Market Perform to Outperform.
04-01 04:24
10x Genomics Seen As Key Player In AI-Driven Biological Data Buildout
William Blair upgrades 10x Genomics, citing AI-driven data demand, improving execution and Xenium validation as key growth drivers.
04-01 02:10
10x Genomics Partners On Global AI Biology Atlas Initiative
Bioptimus, a global AI company building the world's first world model for biology, today announced the launch of its Spatial Tissue Embedding Learning Atlas (STELA), a multinational spatial data generation initiative
03-25 19:07
Breaking Down 10x Genomics: 11 Analysts Share Their Views
Ratings for 10x Genomics (NASDAQ:TXG) were provided by 11 analysts in the past ...
03-03 04:01
Expert Outlook: 10x Genomics Through The Eyes Of 10 Analysts
During the last three months, 10 analysts shared their evaluations of 10x Genom...
02-14 05:00
Earnings Scheduled For February 12, 2026
Companies Reporting Before The Bell • Ambev (NYSE:ABEV) is estimated to report ...
02-12 19:11
